LPTX News and Press, Leap Therapeutics Inc. From 07/26/21

Leap Therapeutics to Present at the ESMO 2021 Virtual Congress PR Newswire CAMBRIDGE, Mass. , July 26, 2021 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today ...

Leap Therapeutics to Present at Ladenburg Thalmann 2021 Virtual Healthcare Conference PR Newswire CAMBRIDGE, Mass. , July 7, 2021 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncolog...

Leap Therapeutics to Present at Raymond James 2021 Virtual Human Health Innovation Conference PR Newswire CAMBRIDGE, Mass. , June 14, 2021 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and i...

Senseonics Holdings SENS +34% on the study results for glucose monitoring system.Windtree Therapeutics (WINT) +28%.The9 Limited NCTY +18% on Montcrypto acquisition.SemiLEDs Corporation (LEDS) +16%.Q&K International Group Limited (QK) +15%.Core Laboratories N.V. (CLB) +...

Leap Therapeutics (LPTX) Q1 GAAP EPS of -$0.12.Cash and cash equivalents totaled $43.5M at March 31, 2021.License revenues for each of the first quarter 2021 and 2020 were $0.375M, and relate to the BeiGene Agreement for the development and commercialization of DKN-01.Shares +8%Pres...

Leap Therapeutics Reports First Quarter 2021 Financial Results PR Newswire CAMBRIDGE, Mass. , May 14, 2021 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today r...

Leap Therapeutics and Flagship Biosciences Develop Image Analysis RNAscope Assay for Prospective Trial Enrollment PR Newswire CAMBRIDGE, Mass. and WESTMINSTER, Colo. , May 12, 2021 /PRNewswire/ -- Leap Therapeutics (Nasdaq: LPTX), a biotechnology comp...

Leap Therapeutics (LPTX) and Flagship Biosciences announce a partnership to use a clinically validated tumor expression assay utilizing RNAscope and tissue image analysis.In a recent poster shared at the American Association for Cancer Research ((AACR)) Annual Meeting 2021, the comp...

Flagship Biosciences and Leap Therapeutics Announce Partnership and Approach Using RNAscope and Image Analysis for Patient Enrollment Laboratory Developed Test for Manual and Image Analysis-assisted Pathologist Interpretation PR Newswire WESTMINSTER, Colo. and ...

Leap Therapeutics Announces Completion of Enrollment for First-Line Patient Cohort in Study of DKN-01 in Combination with Tislelizumab for the Treatment of Gastric or Gastroesophageal Junction Cancer PR Newswire CAMBRIDGE, Mass. , April 1, 2021 /PRNewswire/ -- Le...